JP Morgan Chase’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.92M Buy
1,489,509
+269,630
+22% +$1.85M ﹤0.01% 2679
2025
Q4
$2.42M Buy
1,219,879
+161,911
+15% +$367K ﹤0.01% 3938
2025
Q3
$2.6M Sell
1,057,968
-13,768
-1% -$35.5K ﹤0.01% 3880
2025
Q2
$2.83M Buy
1,071,736
+52,782
+5% +$142K ﹤0.01% 3650
2025
Q1
$3.07M Sell
1,018,954
-22,909
-2% -$69.4K ﹤0.01% 3557
2024
Q4
$2.67M Sell
1,041,863
-99,048
-9% -$413K ﹤0.01% 3929
2024
Q3
$4.24M Sell
1,140,911
-42,505
-4% -$197K ﹤0.01% 3330
2024
Q2
$7.48M Sell
1,183,416
-252,330
-18% -$1.66M ﹤0.01% 2718
2024
Q1
$7.71M Buy
1,435,746
+13,534
+1% +$61.3K ﹤0.01% 2724
2023
Q4
$7.14M Sell
1,422,212
-26,220
-2% -$82.3K ﹤0.01% 2789
2023
Q3
$2.45M Sell
1,448,432
-30,521
-2% -$61.3K ﹤0.01% 3410
2023
Q2
$4.11M Sell
1,478,953
-134,344
-8% -$380K ﹤0.01% 3028
2023
Q1
$2.94M Buy
1,613,297
+80,170
+5% +$249K ﹤0.01% 3256
2022
Q4
$7.77M Sell
1,533,127
-30,136
-2% -$165K ﹤0.01% 2470
2022
Q3
$7.77M Buy
1,563,263
+401,369
+35% +$1.83M ﹤0.01% 2362
2022
Q2
$4.32M Sell
1,161,894
-27,269
-2% -$110K ﹤0.01% 2905
2022
Q1
$6.67M Sell
1,189,163
-82,029
-6% -$503K ﹤0.01% 2753
2021
Q4
$7.73M Buy
1,271,192
+75,883
+6% +$570K ﹤0.01% 2677
2021
Q3
$11.6M Buy
1,195,309
+572,285
+92% +$6.3M ﹤0.01% 2254
2021
Q2
$8.9M Buy
623,024
+79,325
+15% +$1.31M ﹤0.01% 2530
2021
Q1
$12.9M Buy
543,699
+221,183
+69% +$5.73M ﹤0.01% 2127
2020
Q4
$4.3M Buy
322,516
+308,766
+2,246% +$2.97M ﹤0.01% 2937
2020
Q3
$98K Sell
13,750
-73,519
-84% -$733K ﹤0.01% 4701
2020
Q2
$1.07M Buy
87,269
+56,332
+182% +$318K ﹤0.01% 3470
2020
Q1
$89K Sell
30,937
-126,308
-80% -$633K ﹤0.01% 4556
2019
Q4
$596K Buy
157,245
+30,604
+24% +$52.1K ﹤0.01% 4153
2019
Q3
$154K Sell
126,641
-2,860
-2% -$3.55K ﹤0.01% 4737
2019
Q2
$136K Sell
129,501
-7,368
-5% -$8.5K ﹤0.01% 4815
2019
Q1
$216K Buy
136,869
+22,031
+19% +$27.7K ﹤0.01% 4603
2018
Q4
$132K Buy
114,838
+3,197
+3% +$7.31K ﹤0.01% 4738
2018
Q3
$413K Buy
111,641
+63,689
+133% +$201K ﹤0.01% 4371
2018
Q2
$147K Buy
47,952
+1,884
+4% +$6.98K ﹤0.01% 4697
2018
Q1
$179K Buy
46,068
+13,366
+41% +$58.6K ﹤0.01% 4413
2017
Q4
$147K Buy
32,702
+7,123
+28% +$33.7K ﹤0.01% 4532
2017
Q3
$140K Sell
25,579
-128,556
-83% -$792K ﹤0.01% 4214
2017
Q2
$1.17M Buy
154,135
+27,974
+22% +$121K ﹤0.01% 3344
2017
Q1
$447K Sell
126,161
-15,898
-11% -$78.6K ﹤0.01% 3759
2016
Q4
$813K Sell
142,059
-190
-0.1% -$1.27K ﹤0.01% 3533
2016
Q3
$1.11M Sell
142,249
-5,998
-4% -$44.8K ﹤0.01% 3089
2016
Q2
$922K Sell
148,247
-3,949
-3% -$30.7K ﹤0.01% 3214
2016
Q1
$1.25M Buy
152,196
+3,309
+2% +$31.2K ﹤0.01% 2959
2015
Q4
$2.58M Sell
148,887
-308,572
-67% -$4.58M ﹤0.01% 2630
2015
Q3
$5.24M Buy
+457,459
New +$9.98M ﹤0.01% 2192

Other funds holding IBRX